n-3 fatty acids no benefit for high-risk cardio patients
(HealthDay)—For patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who have not had a myocardial infarction, daily treatment with n-3 fatty acids does not reduce cardiovascular ...
Cardiology
May 09, 2013 |
not rated yet |
0
Mayo Clinic creates institution-wide electronic prolonged QT interval warning system
Using a one-of-a-kind computer-aided program, Mayo Clinic has developed and implemented a Mayo-wide electronic warning system to identify patients at risk of QT-related deaths from an abnormality in the heart's electrical ...
Cardiology
Apr 25, 2013 |
not rated yet |
0
Schizophrenia sufferers miss out on heart disease diagnosis
(Medical Xpress)—Those diagnosed with schizophrenia are less likely than the general population to have a recorded diagnosis of heart disease, a new report published in BMJ Open has found.
Psychology & Psychiatry
Apr 22, 2013 |
5 / 5 (1) |
0
Routine cinacalcet for end stage kidney disease not warranted
Cinacalcet, a drug commonly given to patients with end stage kidney disease to help keep phosphorus and parathyroid blood levels within a target range and has few patient level clinical benefits and several adverse effects, ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
not rated yet |
0
